Kuros Biosciences
Kuros Biosciences is a pioneering biotech company focused on innovative bone graft technologies to improve spinal fusion outcomes.
Company facts
- Founded
- 2016
- Headquarters
- Switzerland
- CEO
- Chris Fair
About
At Kuros Biosciences, we face the challenge of spine-related pain that affects countless individuals and medical systems globally. Our company is dedicated to alleviating the burden of spine-related conditions with cutting-edge solutions and innovative biologic technologies. Our flagship product, MagnetOs™, stands out with its unique NeedleGrip™ surface technology that enables effective bone growth in soft tissues, leading to more predictable fusion outcomes for patients. As a Swiss-headquartered firm with over 150 years of combined research experience, our devotion to advancing spine surgery is evidenced by our impressive track record of scientific publications and clinical trials. With a presence across three continents and over 20 global markets, we are positioned to lead in the field of biologics for spinal fusion.